CLASS II ONGOING Device recall · Reported 18 Oct 2023 · FDA Enforcement Report

Empowr 3D Knee Tibial Insert, 5R, VE recalled by Encore Medical

Encore Medical is recalling Empowr 3D Knee Tibial Insert, 5R, VE, distributed nationwide in the US. The recall was initiated on 22 Aug 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 00888912167321, Lot: 075T1167, Expiration: March 30, 2028
Quantity recalled36

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0102-2024
FDA event ID
93098
Recalling firm
Encore Medical, Austin, TX
Classification
Class II
Status
Ongoing
Recall initiated
22 Aug 2023
FDA classified
12 Oct 2023
Reported
18 Oct 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

22 Aug 2023Recall initiated by company
12 Oct 2023Classified by FDA+51 days
18 Oct 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Knee insert and acetabular system parts were swapped within inner pack prior to the product being sealed within the tray, which could result in surgeons not having the correct product for the surgery due to different anatomies (Hip vs Knee).

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

EMPOWR 3D Knee Tibial Insert, 5R, 10MM, VE, REF: 342-10-705

Where it was distributed

US Nationwide distribution in the states of FL, CA, IN, HI, LA, MN, AZ, TX, NJ, PA, KS, TN, PR, SC, WA.

Nationwide ArizonaCaliforniaFloridaHawaiiIndianaKansasLouisianaMinnesotaNew JerseyPennsylvaniaPuerto RicoSouth CarolinaTennesseeTexasWashington

Questions about this recall

Why was it recalled?

Knee insert and acetabular system parts were swapped within inner pack prior to the product being sealed within the tray, which could result in surgeons not having the correct product for the surgery due to different anatomies (Hip vs Knee).

Which lots are affected?

UDI-DI: 00888912167321, Lot: 075T1167, Expiration: March 30, 2028

Where was it sold?

US Nationwide distribution in the states of FL, CA, IN, HI, LA, MN, AZ, TX, NJ, PA, KS, TN, PR, SC, WA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 93098

This product is part of a recall event; the main page for the event is Empowr Acetabular System, Liner, 10¿ Hooded, HXe+, 40H recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IIEmpowr Acetabular System, Liner, 10¿ Hooded, HXe+, 40H recalledEncore MedicalPackaging DefectsNationwide

More recalls from Encore Medical

All 99

Other Hip & Knee Implants recalls

All 3,097